Description

Progestogens, such as progesterone (P4), medroxyprogesterone acetate (MPA), and micronized progesterone (mP4), are given to ovary-intact women during the transition to menopause to attenuate heavy uterine bleeding and other symptoms.

Progestogens, such as progesterone (P4), medroxyprogesterone acetate (MPA), and micronized progesterone (mP4), are given to ovary-intact women during the transition to menopause to attenuate heavy uterine bleeding and other symptoms. Both progesterone and MPA administration have been shown to impair cognition in ovariectomized (Ovx) rats compared to vehicle-treated controls. mP4, however, has yet to be investigated for cognitive effects in a preclinical setting.

447.89 KB application/pdf

Download count: 0

Details

Contributors
Date Created
  • 2019
Resource Type
  • Text
  • Collections this item is in
    Note
    • Partial requirement for: M.A., Arizona State University, 2019
      Note type
      thesis
    • Includes bibliographical references
      Note type
      bibliography
    • Field of study: Psychology

    Citation and reuse

    Statement of Responsibility

    by Veronica Leigh Pena

    Machine-readable links